Skip to main navigation Skip to search Skip to main content

Clinical application of rapid diagnostic test kit for SARS-CoV-2 antibodies into the field of patient care

Research output: Contribution to journalArticlepeer-review

Abstract

Clinical applicability of rapid diagnostic test kit for SARS-CoV-2 antibodies was evaluated. The kit detected antibodies from day 9–56 of illness. IgG bands were observed up to 1: 1000 dilutions. The kit could detect 90.5% of IgG and 61.9% of IgM antibodies of mild febrile patients without pneumonia.

Original languageEnglish
Pages (from-to)97-100
Number of pages4
JournalJournal of Microbiology, Immunology and Infection
Volume54
Issue number1
DOIs
StatePublished - Feb 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Antibody
  • Point-of-care test
  • Rapid diagnostic test
  • SARS-CoV-2
  • Titration

Fingerprint

Dive into the research topics of 'Clinical application of rapid diagnostic test kit for SARS-CoV-2 antibodies into the field of patient care'. Together they form a unique fingerprint.

Cite this